HIV FRAMESHIFTING--FROM BIOLOGY TO THERAPEUTICS
HIV FRAMESHIFTING--FROM BIOLOGY TO THERAPEUTICS
批准号:
6020023
负责人:
STUART W PELTZ
金额:
$12.34万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2004-01-31
中文摘要
描述(改编自申请人摘要):核糖体的能力
英文摘要
DESCRIPTION (Adapted from applicant's abstract): The ability of ribosomes to
maintain the correct translational reading frame is fundamental to the
integrity of protein synthesis and to cell growth and viability. However, there
are now a number of examples utilized by viruses in which elongating ribosomes
are programmed to shift their translational reading frame one base in the 5'
direction. This process is called programmed -1 ribosomal frame-shifting.
Programmed -1 ribosomal frame-shifting is utilized uniquely by eucaryotic
viruses, making it a compelling target for developing antiviral agents. The
human immunodeficiency virus type 1 (HIV-1) utilizes a programmed -1 ribosomal
frameshift to synthesize both the gag and gag-pol proteins from a single
transcript. They have been investigating the cis-acting elements and
trans-acting factors that determine programmed -1 ribosomal frame-shifting
efficiencies in the yeast Saccharomyces cerevisiae. Using the double-stranded
L-A virus system, they have shown that small changes in the ratio of the gag to
gag-pol synthesized by altering frame-shifting efficiency leads to a loss of
the killer virus. These findings have led them to develop the concept that
antiviral agents can be identified that alter the efficiency of programmed
frame-shifting without dramatically affecting global protein synthesis. They
have successfully demonstrated this principle using the yeast killer virus
system as the model, and more recently, with HIV in mammalian cells. Based on
these investigations, they propose to characterize programmed -1 frame-shifting
in HIV-1 with the goal of developing this virus specific mechanism as a target
for antiviral intervention. The aims of the experiments proposed in this grant
proposal will be to characterize the sequences that promote efficient
frame-shifting in HIV-1 and to determine the affects of altering frame-shifting
efficiency on HIV production. They will also characterize further determine if
putative compounds that alter programmed -1 frame-shifting and promote loss of
the killer virus will also reduce or eliminate HIV production. Additional
compounds that affect programmed frame-shifting will also be identified.
Finally, they will investigate at the molecular level how compounds that affect
programmed frame-shifting function. Their long-term goal will be to develop
compounds that affect frame-shifting to the point that proof of principle has
been established and antiviral agents targeting this process will be
subsequently developed for clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Regulation by the TNF Alpha AU-rich Element
-
批准号:6726750
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2003
-
负责人:STUART W PELTZ
-
依托单位:
Complex Involved In mRNA Decay in Yeast
-
批准号:6682684
-
项目类别:
-
资助金额:$30.39万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
Complex Involved In mRNA Decay in Yeast
-
批准号:6797330
-
项目类别:
-
资助金额:$30.82万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
Complex Involved In mRNA Decay in Yeast
-
批准号:6941767
-
项目类别:
-
资助金额:$30.81万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
COMPLEX INVOLVED IN MRNA DECAY IN YEAST
-
批准号:2849128
-
项目类别:
-
资助金额:$27.02万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
COMPLEX INVOLVED IN MRNA DECAY IN YEAST
-
批准号:6519924
-
项目类别:
-
资助金额:$28.05万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
COMPLEX INVOLVED IN MRNA DECAY IN YEAST
-
批准号:6384329
-
项目类别:
-
资助金额:$27.27万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
HIV FRAMESHIFTING--FROM BIOLOGY TO THERAPEUTICS
-
批准号:2798211
-
项目类别:
-
资助金额:$12.44万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
HIV FRAMESHIFTING--FROM BIOLOGY TO THERAPEUTICS
-
批准号:6497114
-
项目类别:
-
资助金额:$25.26万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
HIV FRAMESHIFTING--FROM BIOLOGY TO THERAPEUTICS
-
批准号:6627876
-
项目类别:
-
资助金额:$26.02万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
HIV FRAMESHIFTING--FROM BIOLOGY TO THERAPEUTICS
-
批准号:6149738
-
项目类别:
-
资助金额:$23.81万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
HIV FRAMESHIFTING--FROM BIOLOGY TO THERAPEUTICS
-
批准号:6349871
-
项目类别:
-
资助金额:$24.52万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
COMPLEX INVOLVED IN MRNA DECAY IN YEAST
-
批准号:6181280
-
项目类别:
-
资助金额:$26.48万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
Complex Involved In mRNA Decay in Yeast
-
批准号:7115667
-
项目类别:
-
资助金额:$30.08万
-
财政年份:1999
-
负责人:STUART W PELTZ
-
依托单位:
NONSENSE-MEDIATED MRNA DECAY PATHWAY
-
批准号:2186139
-
项目类别:
-
资助金额:$24.04万
-
财政年份:1993
-
负责人:STUART W PELTZ
-
依托单位:
Nonsense Mediated mRNA Decay Pathway
-
批准号:6688333
-
项目类别:
-
资助金额:$41.76万
-
财政年份:1993
-
负责人:STUART W PELTZ
-
依托单位:
NONSENSE-MEDIATED MRNA DECAY PATHWAY
-
批准号:2186138
-
项目类别:
-
资助金额:$17.72万
-
财政年份:1993
-
负责人:STUART W PELTZ
-
依托单位:
NONSENSE MEDIATED MRNA DECAY PATHWAY
-
批准号:2396061
-
项目类别:
-
资助金额:$36.09万
-
财政年份:1993
-
负责人:STUART W PELTZ
-
依托单位:
NONSENSE MEDIATED MRNA DECAY PATHWAY
-
批准号:6138456
-
项目类别:
-
资助金额:$40.04万
-
财政年份:1993
-
负责人:STUART W PELTZ
-
依托单位:
NONSENSE-MEDIATED MRNA DECAY PATHWAY
-
批准号:2022668
-
项目类别:
-
资助金额:$26.22万
-
财政年份:1993
-
负责人:STUART W PELTZ
-
依托单位:
海外基金